Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 25, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on August 25, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 2,029 Common Stock at $516.12 ($1,047,205) on August 25, 2026; holds 331,914 after (Indirect).
- Open-market sale: disposed of 2,332 Common Stock at $516.95 ($1,205,518) on August 25, 2026; holds 329,582 after (Indirect).
- Open-market sale: disposed of 2,004 Common Stock at $518.08 ($1,038,238) on August 25, 2026; holds 327,578 after (Indirect).
- Open-market sale: disposed of 2,387 Common Stock at $518.80 ($1,238,375) on August 25, 2026; holds 325,191 after (Indirect).
- Open-market sale: disposed of 668 Common Stock at $519.91 ($347,297) on August 25, 2026; holds 324,523 after (Indirect).
- Open-market sale: disposed of 80 Common Stock at $520.50 ($41,640) on August 25, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on August 25, 2026; holds 65,910 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,918,273 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-25 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-08-25 | Open-market sale | Common Stock | 2,029 | $516 | $1.0M | 331,914 |
| 2026-08-25 | Open-market sale | Common Stock | 2,332 | $517 | $1.2M | 329,582 |
| 2026-08-25 | Open-market sale | Common Stock | 2,004 | $518 | $1.0M | 327,578 |
| 2026-08-25 | Open-market sale | Common Stock | 2,387 | $519 | $1.2M | 325,191 |
| 2026-08-25 | Open-market sale | Common Stock | 668 | $520 | $347.3K | 324,523 |
| 2026-08-25 | Open-market sale | Common Stock | 80 | $520 | $41.6K | 324,443 |
| 2026-08-25 | Option exercise/conversion | Stock Option | 9,500 | — | — | 65,910 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-25 | Option exercise/conversion (9,500 shares) |
| 2026-08-25 | Open-market sale (2,029 shares) |
| 2026-08-25 | Open-market sale (2,332 shares) |
| 2026-08-25 | Open-market sale (2,004 shares) |
| 2026-08-25 | Open-market sale (2,387 shares) |
| 2026-08-25 | Open-market sale (668 shares) |
| 2026-08-25 | Open-market sale (80 shares) |
| 2026-08-25 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.